We are live on ! Find out more
NYMX

Nymox Pharmaceutical Corp
NYMX

Delisted

NYMX was delisted on the 6th of July, 2023.

Back to rankings

2 hedge funds and large institutions have $26.6K invested in Nymox Pharmaceutical Corp in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% less funds holding

Funds holding: 5 → 2 (-3)

61% less capital invested

Capital invested by funds: $68.3K → $26.6K (-$41.7K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
2
Holders Change
-3
Holders Change %
-60%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
DDC
DF Dent & Co
Maryland
-$39.4K
2
ODIJL
One Day In July LLC
Vermont
-$5.25K
Name Holding Trade Value Shares
Change 		Change in
Stake
FCFC
1
First Citizens Financial Corp
Iowa
$20.7K – – –
CAM
2
Cubic Asset Management
Massachusetts
$5.9K – – –
DDC
3
DF Dent & Co
Maryland
– -$39.4K -75,000 Closed
ODIJL
4
One Day In July LLC
Vermont
– -$5.25K -10,000 Closed

NYMX Hedge Fund Activity: Q4 2023 in Review

2 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q4 2023, worth a combined $26.6K — down 61% from $68.3K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of NYMX and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was DF Dent & Co, exiting entirely with an estimated $39.4K sold.

  • 2 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q4 2023, down from 5 in Q3 2023.
  • Funds reported $26.6K of Nymox Pharmaceutical Corp stock for Q4 2023, down 61% quarter-over-quarter.
  • 0 funds opened new Nymox Pharmaceutical Corp positions in Q4 2023 and 2 closed out, a net change of -2 holders.
  • The largest Nymox Pharmaceutical Corp seller in Q4 2023 was DF Dent & Co, an estimated $39.4K sold.

Based on aggregated 13F filings for Q4 2023.